← Leaderboards
Rajappa Kenchappa
Transgenex Nanobiotech, Inc.
$1,475,002
Attributed
$1,475,002
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,475,002 · 1
By mechanism
N44$1,475,002 · 1
Top collaborators
No co-investigators on record.
Most similar at Transgenex Nanobiotech, Inc.
Same institution · by research overlap
- Weidong Xu$181,482
- Mahasweta Das$449,998
- Rajesh Nair$225,000
Others in their field
Other Emerging Leaders on “Acute Toxicity”
- Xinhua Li · Nano Terra, Inc.$12,602,356
- Vera Hoffman · Reveal Pharma$8,847,804
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
- Farhang Alem · George Mason University$7,525,547
- Edward Burgard · Dignify Therapeutics, Llc$6,862,973
- George R Uhl · National Institute On Drug Abuse$6,823,425
Research focus
Acute ToxicityAtrial Natriuretic Factor Receptor AComputer SimulationContractsDocumentationDrug KineticsGenerationsInhibitor/AntagonistLeadMalignant Neoplasm Of LungMalignant NeoplasmsNovel TherapeuticsPharmacodynamicsPhase 2 StudyRelapseResearch And DevelopmentScientistSmall Business Innovation Research GrantSmall Molecule LibrariesStem CellsTargeted TreatmentToxic EffectTumorTumor Progression